Market Place
Sourcing Support
Tevogen Bio names David E. Banko Global Head of Government Affair
25 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio Develops Unique T Cell Vaccine, Files USPTO Patent
10 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio CIO Mittul Mehta Speaks at Proskauer`s AI Panel
07 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio to Receive $8 M of Non-Dilutive Grant Funding
03 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Ryan Saadi Named To 2025 NJBIZ Power 100
28 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio Reports 600% Higher Market Cap Per Team Member
21 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Talks Short Selling’s Impact On Health
14 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio Shares 2024 Financing On 1-Year Public Listing
14 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Commits To Retention Of Equity Capital
14 Feb 2025 //
GLOBENEWSWIRE
Tevogen CEO Congratulates RFK Jr. On HHS Secretary Confirmation
13 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio Tackles Biopharma Challenges With Cost-Efficient Model
10 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio`s Business Model Address Biopharma Industry Challenges
10 Feb 2025 //
GLOBENEWSWIRE
Tevogen Highlights ExacTcell™ As Scalable Medical Countermeasure
07 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio To Receive Up To $10M In Non-Dilutive Grant Funding
28 Jan 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Congratulates Lynne Patton On Appointment
27 Jan 2025 //
GLOBENEWSWIRE
Tevogen Bio Expands AI Collaboration With Microsoft On Azure
24 Jan 2025 //
GLOBENEWSWIRE
Tevogen Bio Highlights AI-Driven Drug Development At JPM Conference
23 Jan 2025 //
GLOBENEWSWIRE
Tevogen Bio Hosts Panels on AI, Health Economics at JP Morgan
26 Dec 2024 //
GLOBENEWSWIRE
Tevogen Bio to Host AI in Biopharma Panel at JP Morgan
23 Dec 2024 //
GLOBENEWSWIRE
Tevogen Bio Strengthens IP with AI Patent to T Cell Therapies
19 Dec 2024 //
GLOBENEWSWIRE
Tevogen Bio Host Panel on Economics at 43rd J.P. Morgan Conference
17 Dec 2024 //
GLOBENEWSWIRE
Tevogen Bio to Attend 43rd J.P. Morgan Healthcare Conference
10 Dec 2024 //
GLOBENEWSWIRE
Dr. Ryan Saadi Commends Public Service & Congratulates Mayor
05 Dec 2024 //
GLOBENEWSWIRE
Tevogen Bio Prepares for Growth Strategy Support
26 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio CEO Reflects on Public Support, Prioritizes Value
21 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Reports Q3 2024 Results, Improves Financial Position
19 Nov 2024 //
GLOBENEWSWIRE
Tevogen Founder Reflects on Preserving Shareholder Value
14 Nov 2024 //
GLOBENEWSWIRE
Tevogen Founder Reflects on Shareholder Value Amid Growth
14 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Nears R&D, Manufacturing Deal & $36M Credit
08 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Partners with Microsoft for HPV Target Identification
05 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio CEO Ryan Saadi Recognized for Business Model
05 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Appoints Anthony Tarantino as Patient Advocate
04 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Partners with Microsoft to Accelerate Drug Development
31 Oct 2024 //
GLOBENEWSWIRE
Tevogen Signs LOI with CD8 for $50M R&D Facility; No Equity Impact
29 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Reports Nasdaq Compliance, CEO Commits to Info Bridge
29 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Provides T Cell Therapy Guidance for Oncology
25 Oct 2024 //
GLOBENEWSWIRE
Tevogen AI Partners with Microsoft for Drug Development
23 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio To Provide Revenue Forecast Timelines This Week
22 Oct 2024 //
GLOBENEWSWIRE
Tevogen Provides Clarity On CSO Share Sales For Tax Obligations
21 Oct 2024 //
GLOBENEWSWIRE
Tevogen Reports Revenue Forecast Of Nearly $1 Billion In Launch Year
21 Oct 2024 //
GLOBENEWSWIRE
Tevogen CEO Thanks Public For Support Of Patient Model.
18 Oct 2024 //
GLOBENEWSWIRE
Tevogen Investors Celebrate Recognition Of Biopharma Model
17 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Forecasts $1B Revenue In Launch Year, $10-14B Over 5
17 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Thanks Warren Township For Honoring CEO Dr. Ryan Saadi
16 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Highlights the Publication of Promising Trial Data
15 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Leads in Developing Cell Therapies For HPV In Women
15 Oct 2024 //
GLOBENEWSWIRE
Tevogen CEO Reaffirms Commitment To Closing Information Gap
14 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Extends Pipeline Prioritizing Oncology and Long COVID
11 Oct 2024 //
GLOBENEWSWIRE
Tevogen To Share $1B+ Revenue Potential Of Pipeline On 14th Oct 2024
11 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Highlights Trial Data And CEO Leads Patient Advocacy
08 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Meets Congress, Highlights Biotech Innovation
24 Sep 2024 //
GLOBENEWSWIRE
Tevogen Bio Secures $6 Million Series C Preferred Stock Investment
22 Aug 2024 //
GLOBENEWSWIRE
Tevogen Bio Eliminates Going Concern Doubts, Series B Preferred Shares
15 Aug 2024 //
GLOBENEWSWIRE
Tevogen Bio Q2 2024 Results, Eliminates Going Concern Doubts, Series B Shares
15 Aug 2024 //
GLOBENEWSWIRE
Tevogen Bio’s Advisory Chair, Professor Sten Vermund, Named USF Dean
14 Aug 2024 //
GLOBENEWSWIRE
Tevogen Bio CEO Reaffirms Growth Strategy, Clarifies S-1 Filing
09 Aug 2024 //
GLOBENEWSWIRE
Tevogen Bio Highlights Achievements And Considers Share Buyback
11 Jul 2024 //
GLOBENEWSWIRE
Tevogen Bio Discusses Unmodified T Cell Tech With Nasdaq`s Ayanian
10 Jul 2024 //
GLOBENEWSWIRE
Ryan Saadi Congratulates Marc Benioff On Yale Award
08 Jul 2024 //
GLOBENEWSWIRE
Tevogen Files Registration Statement for Securities; No New Dilutive Issuances
26 Jun 2024 //
GLOBENEWSWIRE
